Latest News and Press Releases

Chicago, May 10, 2024 (GLOBE NEWSWIRE) -- Vaccines market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0%...

NEWARK, Del, March 29, 2024 (GLOBE NEWSWIRE) -- The global market for live stock vaccines is expected to skyrocket. Its projected valuation of US$ 6.1 billion by 2024 will surge to US$ 11.2 billion...

Pune, India, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Global Vaccines Market Size was valued at USD 55.44 billion in 2020 and is projected to grow from USD 125.49 billion by 2028 exhibiting a CAGR of 10.8%...

Chicago, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Vaccines market in terms of revenue was estimated to be worth $77.6 billion in 2023 and is poised to reach $93.8 billion by 2028, growing at a CAGR of 3.9%...

Visiongain has published a new report entitled mRNA Vaccines Market Report 2023-2033: Forecasts by Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-amplifying mRNA-based Vaccines),...

Visiongain has published a new report entitled Influenza Vaccines Market Report 2023-2033: Forecasts by Vaccine Type (Quadrivalent, Trivalent), by End-users (Specialty Clinics, Hospitals, Others) AND...

Chicago, May 31, 2023 (GLOBE NEWSWIRE) -- The vaccines industry is poised for remarkable growth and advancements in the near future. With the ongoing global focus on infectious diseases and the...

NEW YORK, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Vaccines Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the vaccine market, Market scope, Market...

London, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Augmenting investments from both vaccine manufacturers, and governments are predominantly driving the growth of global vaccines market. In addition, greater...

Chicago, June 17, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease...